Case studiesObesity

Phase 3 · Obesity

Screening in two days. Momentum that continued.

Early engagement with private-practice patients supported the first screening appointment. Recruitment continued beyond that first visit, alongside coordination of outside assessments and counseling.

Explore the work behind the result

Documented result

2days from activation to first screening
22participants screened in total
20participants randomized in total
2screen failures

The work behind the result

Prepare the first visit. Sustain the next ones.

The team’s work continued beyond activation and the first screening appointment.

  • Screening immediately after activation

    The first screening required a prepared candidate as soon as the site was activated.

    How WCR responded

    WCR engaged patients from the investigator’s private practice early. Prescreening and communication helped prepare candidates before the first visit.

  • Sustaining recruitment after the initial group

    A fast first appointment needed to be followed by continued screening activity.

    How WCR responded

    The team continued candidate engagement and prescreening beyond the initial group, supporting the ongoing recruitment effort.

  • Coordinating outside appointments

    Ophthalmology assessments and counseling had to fit alongside research visits.

    How WCR responded

    Staff coordinated ophthalmology appointments, nutrition services, lifestyle counseling, and study visits with participants.

Outcomes in context

An early start followed by continued screening

Five participants screened within the first month after activation and all five subsequently randomized. Additional screening continued at approximately five participants per month.

A complete screening-to-randomization count

The total reported figures were 22 screened, 20 randomized, and two screen failures. The chart shows those totals without inventing monthly observations.

Your next study

Build your next study on a stronger start.

Talk with our Miami Lakes and Puerto Rico teams about your protocol, patient population, and the participation demands that matter to your study.